Lannett (LCI) Chief of Scientific Affairs Mahendra Dedhiya Resigns
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
Lannett Company, Inc. (NYSE: LCI) today announced the resignation of its chief of scientific affairs, Mahendra Dedhiya, Ph.D., effective October 21, 2016.
"Mahendra joined Lannett last year as part of our acquisition of Silarx Pharmaceuticals," said Arthur Bedrosian, chief executive officer of Lannett. "He intends to become a faculty member and researcher at Long Island University, where he had been teaching part time. We thank him for his service to Lannett and wish him well."
The company said a search is underway for a new head of research and development.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lexmark (LXK) Gets CFIUS Approval for Apex Tech Deal
- DTE Energy (DTE) Prices 12M Equity Units Offering
- New York REIT (NYRT) Issues Response to WW Investors; Says Fund Continuing to 'Mislead' Shareholders Regarding Facts
Create E-mail Alert Related CategoriesCorporate News, Management Changes
Related EntitiesDefinitive Agreement
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!